Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Human Embryonic Stem Cells (HESC) Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Human Embryonic Stem Cells (HESC) Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Totipotent Stem Cells
      • 1.3.3 Pluripotent Stem Cells
      • 1.3.4 Unipotent Stem Cells
    • 1.4 Market Segment by Application
      • 1.4.1 Global Human Embryonic Stem Cells (HESC) Market Share by Application (2019-2025)
      • 1.4.2 Research
      • 1.4.3 Clinical Trials
      • 1.4.4 Others
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global Human Embryonic Stem Cells (HESC) Market Size
      • 2.1.1 Global Human Embryonic Stem Cells (HESC) Revenue 2014-2025
      • 2.1.2 Global Human Embryonic Stem Cells (HESC) Sales 2014-2025
    • 2.2 Human Embryonic Stem Cells (HESC) Growth Rate by Regions
      • 2.2.1 Global Human Embryonic Stem Cells (HESC) Sales by Regions 2014-2019
      • 2.2.2 Global Human Embryonic Stem Cells (HESC) Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Human Embryonic Stem Cells (HESC) Sales by Manufacturers
      • 3.1.1 Human Embryonic Stem Cells (HESC) Sales by Manufacturers 2014-2019
      • 3.1.2 Human Embryonic Stem Cells (HESC) Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Human Embryonic Stem Cells (HESC) Revenue by Manufacturers (2014-2019)
      • 3.2.2 Human Embryonic Stem Cells (HESC) Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Human Embryonic Stem Cells (HESC) Market Concentration Ratio (CR5 and HHI)
    • 3.3 Human Embryonic Stem Cells (HESC) Price by Manufacturers
    • 3.4 Key Manufacturers Human Embryonic Stem Cells (HESC) Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Human Embryonic Stem Cells (HESC) Market
    • 3.6 Key Manufacturers Human Embryonic Stem Cells (HESC) Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 Totipotent Stem Cells Sales and Revenue (2014-2019)
      • 4.1.2 Pluripotent Stem Cells Sales and Revenue (2014-2019)
      • 4.1.3 Unipotent Stem Cells Sales and Revenue (2014-2019)
    • 4.2 Global Human Embryonic Stem Cells (HESC) Sales Market Share by Type
    • 4.3 Global Human Embryonic Stem Cells (HESC) Revenue Market Share by Type
    • 4.4 Human Embryonic Stem Cells (HESC) Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Human Embryonic Stem Cells (HESC) Sales by Application

    6 United States

    • 6.1 United States Human Embryonic Stem Cells (HESC) Breakdown Data by Company
    • 6.2 United States Human Embryonic Stem Cells (HESC) Breakdown Data by Type
    • 6.3 United States Human Embryonic Stem Cells (HESC) Breakdown Data by Application

    7 European Union

    • 7.1 European Union Human Embryonic Stem Cells (HESC) Breakdown Data by Company
    • 7.2 European Union Human Embryonic Stem Cells (HESC) Breakdown Data by Type
    • 7.3 European Union Human Embryonic Stem Cells (HESC) Breakdown Data by Application

    8 China

    • 8.1 China Human Embryonic Stem Cells (HESC) Breakdown Data by Company
    • 8.2 China Human Embryonic Stem Cells (HESC) Breakdown Data by Type
    • 8.3 China Human Embryonic Stem Cells (HESC) Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World Human Embryonic Stem Cells (HESC) Breakdown Data by Company
    • 9.2 Rest of World Human Embryonic Stem Cells (HESC) Breakdown Data by Type
    • 9.3 Rest of World Human Embryonic Stem Cells (HESC) Breakdown Data by Application
    • 9.4 Rest of World Human Embryonic Stem Cells (HESC) Breakdown Data by Countries
      • 9.4.1 Rest of World Human Embryonic Stem Cells (HESC) Sales by Countries
      • 9.4.2 Rest of World Human Embryonic Stem Cells (HESC) Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 ESI BIO
      • 10.1.1 ESI BIO Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of Human Embryonic Stem Cells (HESC)
      • 10.1.4 Human Embryonic Stem Cells (HESC) Product Introduction
      • 10.1.5 ESI BIO Recent Development
    • 10.2 Thermo Fisher
      • 10.2.1 Thermo Fisher Company Details
      • 10.2.2 Company Description and Business Overview
      • 10.2.3 Sales, Revenue and Market Share of Human Embryonic Stem Cells (HESC)
      • 10.2.4 Human Embryonic Stem Cells (HESC) Product Introduction
      • 10.2.5 Thermo Fisher Recent Development
    • 10.3 BioTime
      • 10.3.1 BioTime Company Details
      • 10.3.2 Company Description and Business Overview
      • 10.3.3 Sales, Revenue and Market Share of Human Embryonic Stem Cells (HESC)
      • 10.3.4 Human Embryonic Stem Cells (HESC) Product Introduction
      • 10.3.5 BioTime Recent Development
    • 10.4 MilliporeSigma
      • 10.4.1 MilliporeSigma Company Details
      • 10.4.2 Company Description and Business Overview
      • 10.4.3 Sales, Revenue and Market Share of Human Embryonic Stem Cells (HESC)
      • 10.4.4 Human Embryonic Stem Cells (HESC) Product Introduction
      • 10.4.5 MilliporeSigma Recent Development
    • 10.5 BD Biosciences
      • 10.5.1 BD Biosciences Company Details
      • 10.5.2 Company Description and Business Overview
      • 10.5.3 Sales, Revenue and Market Share of Human Embryonic Stem Cells (HESC)
      • 10.5.4 Human Embryonic Stem Cells (HESC) Product Introduction
      • 10.5.5 BD Biosciences Recent Development
    • 10.6 Astellas Institute of Regenerative Medicine
      • 10.6.1 Astellas Institute of Regenerative Medicine Company Details
      • 10.6.2 Company Description and Business Overview
      • 10.6.3 Sales, Revenue and Market Share of Human Embryonic Stem Cells (HESC)
      • 10.6.4 Human Embryonic Stem Cells (HESC) Product Introduction
      • 10.6.5 Astellas Institute of Regenerative Medicine Recent Development
    • 10.7 Asterias Biotherapeutics
      • 10.7.1 Asterias Biotherapeutics Company Details
      • 10.7.2 Company Description and Business Overview
      • 10.7.3 Sales, Revenue and Market Share of Human Embryonic Stem Cells (HESC)
      • 10.7.4 Human Embryonic Stem Cells (HESC) Product Introduction
      • 10.7.5 Asterias Biotherapeutics Recent Development
    • 10.8 Cell Cure Neurosciences
      • 10.8.1 Cell Cure Neurosciences Company Details
      • 10.8.2 Company Description and Business Overview
      • 10.8.3 Sales, Revenue and Market Share of Human Embryonic Stem Cells (HESC)
      • 10.8.4 Human Embryonic Stem Cells (HESC) Product Introduction
      • 10.8.5 Cell Cure Neurosciences Recent Development
    • 10.9 PerkinElmer
      • 10.9.1 PerkinElmer Company Details
      • 10.9.2 Company Description and Business Overview
      • 10.9.3 Sales, Revenue and Market Share of Human Embryonic Stem Cells (HESC)
      • 10.9.4 Human Embryonic Stem Cells (HESC) Product Introduction
      • 10.9.5 PerkinElmer Recent Development
    • 10.10 Takara Bio
      • 10.10.1 Takara Bio Company Details
      • 10.10.2 Company Description and Business Overview
      • 10.10.3 Sales, Revenue and Market Share of Human Embryonic Stem Cells (HESC)
      • 10.10.4 Human Embryonic Stem Cells (HESC) Product Introduction
      • 10.10.5 Takara Bio Recent Development
    • 10.11 Cellular Dynamics International
    • 10.12 Reliance Life Sciences
    • 10.13 Research & Diagnostics Systems
    • 10.14 SABiosciences
    • 10.15 STEMCELL Technologies
    • 10.16 Stemina Biomarker Discovery
    • 10.17 Takara Bio
    • 10.18 TATAA Biocenter
    • 10.19 UK Stem Cell Bank
    • 10.20 ViaCyte
    • 10.21 Vitrolife

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 Human Embryonic Stem Cells (HESC) Sales Channels
      • 11.2.2 Human Embryonic Stem Cells (HESC) Distributors
    • 11.3 Human Embryonic Stem Cells (HESC) Customers

    12 Market Forecast

    • 12.1 Global Human Embryonic Stem Cells (HESC) Sales and Revenue Forecast 2019-2025
    • 12.2 Global Human Embryonic Stem Cells (HESC) Sales Forecast by Type
    • 12.3 Global Human Embryonic Stem Cells (HESC) Sales Forecast by Application
    • 12.4 Human Embryonic Stem Cells (HESC) Forecast by Regions
      • 12.4.1 Global Human Embryonic Stem Cells (HESC) Sales Forecast by Regions 2019-2025
      • 12.4.2 Global Human Embryonic Stem Cells (HESC) Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      Human embryonic stem cell: also known as a human pluripotent stem cell, one of the "cells that are self-replicating, are derived from human embryos or human fetal tissue, and are known to develop into cells and tissues of the three primary germ layers.
      In 2019, the market size of Human Embryonic Stem Cells (HESC) is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Human Embryonic Stem Cells (HESC).

      This report studies the global market size of Human Embryonic Stem Cells (HESC), especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Human Embryonic Stem Cells (HESC) sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      ESI BIO
      Thermo Fisher
      BioTime
      MilliporeSigma
      BD Biosciences
      Astellas Institute of Regenerative Medicine
      Asterias Biotherapeutics
      Cell Cure Neurosciences
      PerkinElmer
      Takara Bio
      Cellular Dynamics International
      Reliance Life Sciences
      Research & Diagnostics Systems
      SABiosciences
      STEMCELL Technologies
      Stemina Biomarker Discovery
      Takara Bio
      TATAA Biocenter
      UK Stem Cell Bank
      ViaCyte
      Vitrolife

      Market Segment by Product Type
      Totipotent Stem Cells
      Pluripotent Stem Cells
      Unipotent Stem Cells

      Market Segment by Application
      Research
      Clinical Trials
      Others

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Human Embryonic Stem Cells (HESC) status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Human Embryonic Stem Cells (HESC) manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Human Embryonic Stem Cells (HESC) are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now